Treatment of Infectious Enterocolitis
For infectious enterocolitis, broad-spectrum antibiotic therapy targeting enteric pathogens is the primary treatment, using regimens such as ciprofloxacin plus metronidazole or a carbapenem, with duration and intensity guided by severity of illness and source control.
Initial Assessment and Risk Stratification
The context of recent uncomplicated appendicitis raises concern for post-appendectomy infectious complications or a separate gastrointestinal infection. Key distinctions must be made:
- If this represents necrotizing enterocolitis in neonates: Use ampicillin, gentamicin, and metronidazole; or ampicillin, cefotaxime, and metronidazole; or meropenem, with urgent surgical consultation for bowel perforation 1
- If this is post-appendectomy infectious enterocolitis: Treat as complicated intra-abdominal infection with appropriate source control evaluation 1
- If this is community-acquired infectious enterocolitis unrelated to appendicitis: Use community-acquired infection regimens 1
Antibiotic Regimen Selection
For Mild-to-Moderate Community-Acquired Infection
Preferred single-agent regimens 1:
- Ertapenem 1 g every 24 hours 1
- Moxifloxacin 400 mg every 24 hours 1
- Tigecycline 100 mg initial dose, then 50 mg every 12 hours 1
- Ticarcillin-clavulanate 3.1 g every 6 hours 1
Preferred combination regimens 1:
- Metronidazole 500 mg every 8-12 hours PLUS one of: ceftriaxone 1-2 g every 12-24 hours, cefotaxime 1-2 g every 6-8 hours, levofloxacin 750 mg every 24 hours, or ciprofloxacin 400 mg every 12 hours 1
For High-Severity or Healthcare-Associated Infection
Use anti-pseudomonal regimens 1:
- Piperacillin-tazobactam 3.375 g every 6 hours 1
- Imipenem-cilastatin 500 mg every 6 hours or 1 g every 8 hours 1
- Meropenem 1 g every 8 hours 1
- Doripenem 500 mg every 8 hours 1
Duration of Therapy
- With adequate source control: Discontinue antibiotics after 3-5 days maximum 1, 2
- Without complete source control: Continue until clinical resolution, typically 5-7 days 1
- Minimum duration: 48 hours of intravenous therapy before considering oral transition 3, 4
Critical Pitfalls to Avoid
Do NOT use the following agents 1:
- Ampicillin-sulbactam: High E. coli resistance rates (>20%) make this unreliable 1, 2
- Cefotetan or clindamycin: Increasing Bacteroides fragilis resistance renders these inadequate 1, 2
- Quinolones if recent exposure: Avoid moxifloxacin if patient received quinolones within 3 months due to resistance 1
- Quinolones in high-resistance areas: Only use if local E. coli susceptibility is ≥90% 1
Aminoglycosides are not recommended for routine use in adults with community-acquired infection due to toxicity, despite availability of less toxic equally effective alternatives 1
Coverage Considerations
- Enterococcal coverage is NOT required for community-acquired intra-abdominal infection, as multiple trials show no benefit 1
- Antifungal coverage is NOT indicated empirically for community-acquired infection 1
- Exception for neonatal necrotizing enterocolitis: Add fluconazole or amphotericin B if Gram stain or cultures suggest fungal infection 1
Special Populations
For patients with beta-lactam allergy 1, 2:
- Ciprofloxacin 400 mg every 12 hours plus metronidazole 500 mg every 8-12 hours 1
- Moxifloxacin 400 mg every 24 hours (monotherapy) 1
- Aztreonam 1-2 g every 6-8 hours plus metronidazole 1
For pediatric patients 1:
- Acceptable regimens include aminoglycoside-based combinations, carbapenems (imipenem, meropenem, or ertapenem), piperacillin-tazobactam, or advanced cephalosporins (cefotaxime, ceftriaxone, ceftazidime, or cefepime) with metronidazole 1
- Weight-based dosing required with monitoring of aminoglycoside levels 1
Source Control Imperative
Antibiotics alone are insufficient without addressing the infectious source. Evaluate for:
- Undrained abscesses requiring percutaneous or surgical drainage 1
- Bowel perforation requiring surgical intervention 1
- Inadequate initial source control from recent appendectomy 1
If adequate source control is achieved, antibiotics can be discontinued after 24 hours in some cases, though 3-5 days is standard practice 2, 4.